For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
In the latest session, 89bio Inc (NASDAQ: ETNB) closed at $9.02 down -4.85% from its previous closing price of $9.48. In other words, the price has decreased by -$4.85 from its previous closing price. On the day, 1.78 million shares were traded. ETNB stock price reached its highest trading level at $9.49 during the session, while it also had its lowest trading level at $8.79.
Ratios:
For a deeper understanding of 89bio Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 18.03 and its Current Ratio is at 18.03. In the meantime, Its Debt-to-Equity ratio is 0.06 whereas as Long-Term Debt/Eq ratio is at 0.06.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Goldman on March 14, 2025, initiated with a Neutral rating and assigned the stock a target price of $11.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Jul 15 ’25 when Le-Nguyen Quoc sold 10,461 shares for $11.02 per share. The transaction valued at 115,280 led to the insider holds 309,364 shares of the business.
QUOC LE-NGUYEN bought 10,461 shares of ETNB for $115,233 on Jul 15 ’25. On Apr 15 ’25, another insider, Le-Nguyen Quoc, who serves as the insider of the company, sold 15,329 shares for $5.95 each. As a result, the insider received 91,208 and left with 328,323 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ETNB now has a Market Capitalization of 1383929600 and an Enterprise Value of 715576320.
Stock Price History:
The Beta on a monthly basis for ETNB is 1.27, which has changed by 0.15641022 over the last 52 weeks, in comparison to a change of 0.18634176 over the same period for the S&P500. Over the past 52 weeks, ETNB has reached a high of $11.84, while it has fallen to a 52-week low of $4.16. The 50-Day Moving Average of the stock is -9.75%, while the 200-Day Moving Average is calculated to be 3.91%.
Shares Statistics:
For the past three months, ETNB has traded an average of 1.87M shares per day and 1588570 over the past ten days. A total of 145.98M shares are outstanding, with a floating share count of 141.33M. Insiders hold about 3.19% of the company’s shares, while institutions hold 108.79% stake in the company. Shares short for ETNB as of 1752537600 were 15456597 with a Short Ratio of 8.25, compared to 1749772800 on 13985891. Therefore, it implies a Short% of Shares Outstanding of 15456597 and a Short% of Float of 14.739999000000001.
Earnings Estimates
A comprehensive evaluation of 89bio Inc (ETNB) is underway, with the input of 7.0 analysts contributing to its current rating.The consensus estimate for the next quarter is -$0.52, with high estimates of -$0.4 and low estimates of -$0.62.
Analysts are recommending an EPS of between -$1.74 and -$2.36 for the fiscal current year, implying an average EPS of -$2.11. EPS for the following year is -$2.26, with 9.0 analysts recommending between -$1.25 and -$2.87.
